1. Reducing Adverse Side Effects
2. Reducing Risk of Abuse and Addiction
3. Improving Patient Compliance by Documenting Use
4. Improving Communication between Health Care Providers and Patients
5. Reducing Cost of Medications by using Lower Effective Doses
6. Reducing Used Needles
7. Improving Patient Safety by avoiding Medication Errors
For pharmaceutical companies the lower dosage required will permit their production facilities to produce the medications at a lower dosage level. This may potentially lead to:
a. Lower drug costs to the consumer;
b. Greater profit per drug dose to the manufacturer;
c. Reduction in capital expenditures required to construct or increase production capacity;
d. Savings on liability insurance as side effects may be reduced or eliminated;
e. Lower environmental impact due to lower doses;
f. Smaller particle size should eliminate secondhand exposure also reducing environmental impact.
Nebulizer and respiratory devices market is quite mature with jet dominating the market due to its low cost. Hence, other nebulization devices are expected to witness the high competition. However, it is a challenge for new technology or device to gain momentum in mature markets. Jet nebulizers are expected to account for the largest share in the nebulizer market followed by mesh nebulizers. The Ultrasonic nebulizers segment is anticipated to have steady growth owing to the wider range of benefits. There are some major players in the Nebulizer market such as Omron, Koninklijke Philips and PARI comprising the major market share globally. However, an introduction of technologically advanced mesh nebulizers has created many opportunities for companies such as Vectura Group and PARI Pharma. Notably, as per the analysis of U.S. and Europe clinical trial databases,mesh nebulizers are preferred over jet nebulizers in clinical trials sponsored by pharmaceutical companies.
Dosage amounts can be significantly reduced as the medication avoids the “first pass effect” of other delivery methods (i.e. oral) where uptake into the bloodstream is first filtered through the liver and kidneys;
With reduced dosing amounts, it is expected that many of the adverse side effects and / or the need for additional medications to counteract side effects may be significantly reduced or completely eliminated.
With intelligent design features built into the devices such as “lock-out” technologies, and other advanced security features incorporated into the nebulizer, mistaken use of a medication, overdosing, underdosing, and efforts to abuse medications can be eliminated.
Smaller dosing may permit medications with extremely high costs (often referred to as “widow and orphan” drugs) to become cost effective for those in critical need of these treatments; Smaller dosages and the ability to program the PDS to titrate medication amounts down over a period of time will help reduce the risk of, and even provide a method of treatment for dependencies of various narcotics and opioids, nicotine, caffeine, and alcohol.
The device can also be utilized to deliver various supplements such as vitamins and weight loss formulations where necessary
Mean Particle size: 2.13 Microns Capsule
Fill Volume: 0.5-2ml (variable option)
Nebulization rate: 0.2ml/minutes minimum
Opaque mist Battery Life: 1.5 hours of continuous nebulisation